The growing sophistication of tumor molecular profiling has helped to slowly transition oncologic care toward a more personalized approach in different tumor types, including in bladder cancer. The ...

Multiomic Characterization of RCC1 and RCC2 Expression and Their Association With Molecular Alterations, Immune Phenotypes, and Cancer Outcomes This retrospective analysis included patients with ...

Researchers from the University of Washington and the University of Utah observed the DNA difference by analyzing fragments derived from human glioblastoma and hepatocellular carcinoma cells ...

What information could patients and providers learn from DNA found in a blood sample? An expert sat down with CURE to discuss ctDNA misconceptions. For patients with cancer, circulating tumor DNA ...

Dr. Debu Tripathy discusses recent research on the use of circulating tumor DNA in metastatic breast cancer care. Circulating tumor DNA, also referred to as ctDNA, are small pieces of DNA that are ...

This tutorial provides a step-by-step overview of the workflow for isolating cell-free circulating DNA from plasma or serum using the Plasma/Serum Cell-Free Circulating DNA Purification Mini Kit.

This study is led by Prof. Luo Huiyan and Prof. Xu Ruihua (Department of Medical Oncology, Sun Yat Sen University Cancer Center). Colorectal adenomas (CRAs) represent precancerous lesions that precede ...

Detection of molecular residual disease using circulating tumor DNA (ctDNA) may enable postoperative risk stratification and guide adjuvant therapy. We evaluated the prognostic value of a tissue-free, ...

Liver transplant is a lifesaving surgery, but a significant number of patients experience organ rejection or other complications. A study by scientists at Georgetown University and MedStar Health has ...